SCM
QNRX

Stonepine Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Stonepine Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Sell
53,460
-24,729
-32% -$224K 0.14% 61
2025
Q4 		$1.13M Buy
+78,189
New +$1.06M 0.82% 33

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Stonepine Capital Management's QNRX Position: Q1 2026 in Review

Stonepine Capital Management reduced its Quoin Pharmaceuticals (QNRX) stake by 32% in Q1 2026, selling an estimated $224K and leaving 53,460 shares worth $353K. The position accounts for 0.14% of the portfolio, ranked #61.

Stonepine Capital Management first reported a position in QNRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.13M in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Stonepine Capital Management held 53,460 shares of Quoin Pharmaceuticals worth $353K as of Q1 2026.
  • Stonepine Capital Management sold 24,729 Quoin Pharmaceuticals shares in Q1 2026, an estimated $224K.
  • Quoin Pharmaceuticals made up 0.14% of Stonepine Capital Management's portfolio in Q1 2026, its #61 holding.
  • Stonepine Capital Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Stonepine Capital Management's Quoin Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.